Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ropinirole versus levodopa in Parkinson's disease.

× No keyword cloud information.

12 in total

1. Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.

Authors: J T Hutton; L V Metman; T N Chase; J L Juncos; W C Koller; R Pahwa; P A LeWitt; A Samii; J K Tsui; D B Calne; C H Waters; V P Calabrese; J P Bennett; R Barrett; J L Morris
Journal: Mov Disord Date: 2001-05 Impact factor: 10.338

2. Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.

Authors: L V Metman; M Gillespie; C Farmer; F Bibbiani; S Konitsiotis; M Morris; H Shill; W Bara-Jimenez; M M Mouradian; T N Chase
Journal: Clin Neuropharmacol Date: 2001 May-Jun Impact factor: 1.592

3. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

Authors: N Turjanski; A J Lees; D J Brooks
Journal: Neurology Date: 1999-03-23 Impact factor: 9.910

Review 4. Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?

Authors: C W Olanow; D Calne
Journal: Neurology Date: 1992-04 Impact factor: 9.910

Review 5. Slowing Parkinson's disease progression: recent dopamine agonist trials.

Authors: J Eric Ahlskog
Journal: Neurology Date: 2003-02-11 Impact factor: 9.910

6. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.

Authors:
Journal: JAMA Date: 2002-04-03 Impact factor: 56.272

7. Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group.

Authors:
Journal: Ann Neurol Date: 1998-03 Impact factor: 10.422

8. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

Authors:
Journal: JAMA Date: 2000-10-18 Impact factor: 56.272

Review 9. Continuous dopaminergic stimulation in early and advanced Parkinson's disease.

Authors: Fabrizio Stocchi; C Warren Olanow
Journal: Neurology Date: 2004-01-13 Impact factor: 9.910

Review 10. Avoidance of dyskinesia: preclinical evidence for continuous dopaminergic stimulation.

Authors: Peter Jenner
Journal: Neurology Date: 2004-01-13 Impact factor: 9.910